戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                   The study took place in an institutional setting.
2 ruited and evaluated from 2013 to 2017 in an institutional setting.
3 test the transportability of IMRT to a multi-institutional setting.
4 ent can be delivered successfully in a multi-institutional setting.
5  cancer is feasible and effective in a multi-institutional setting.
6 ky and advanced Hodgkin's disease in a multi-institutional setting.
7 vity and toxicity of these agents in a multi-institutional setting.
8 tudy METHODS: This study was conducted in an institutional setting.
9 stration outside of a controlled health care institutional setting.
10                                              Institutional setting.
11 d trials for this disease stage in the multi-institutional setting.
12 ally invasive esophagectomy (MIE) in a multi-institutional setting.
13 al and psychological symptoms, but mainly in institutional settings.
14 developmental deficits in children raised in institutional settings.
15 eaks that involved small numbers of cases in institutional settings.
16 occurrence of clusters in both community and institutional settings.
17 ase are uncommon and have occurred mainly in institutional settings.
18 duals with serious mental illness outside of institutional settings.
19 d on gastric cancer samples across different institutional settings.
20 d in community settings, and 45% occurred in institutional settings.
21  elevations in ADHD among children raised in institutional settings.
22      DESIGN, SETTING, AND PARTICIPANT: In an institutional setting, a patient with open-angle glaucom
23 eoplastic activity of the regimen in a multi-institutional setting and to reduce the incidence of car
24 uses, 19 charitable children's institutions (institutional settings), and a convenience sample of 100
25 n family-based settings, 1230 were living in institutional settings, and 91 were living in street set
26 is resource-intensive and usually limited to institutional settings, community-driven approaches can
27 e adequacy or quality of end-of-life care in institutional settings compared with deaths at home.
28 f these formulas can be validated in diverse institutional settings, decisions regarding short- and l
29 of our toolkit are easily adaptable to other institutional settings during future health emergencies.
30                     Young children raised in institutional settings experience severe deprivation in
31 ppropriate or inappropriate often applied in institutional settings, fails to account for complex fac
32 at patiromer monotherapy may be useful in an institutional setting for managing elevated potassium le
33               This study was conducted in an institutional setting in a pediatric population (aged <1
34 ldren (mean age = 12.9 y) raised in deprived institutional settings in Romania randomized to a high-q
35 ared with less than 50% of those dying in an institutional setting or with home health services (P<.0
36            More such outbreaks are likely in institutional settings, particularly those in which ther
37 wing hospitalization (versus returning to an institutional setting), residing in an area with a high
38         This study was performed, in a multi-institutional setting, to evaluate the efficacy and feas
39 even patients with bilateral cataracts in an institutional setting were included.
40  undergo planned uniocular enucleation in an institutional setting, were randomly divided into 3 grou
41                           Patients within an institutional setting who underwent trabeculectomy with
42 motherapy in the treatment of NPC to a multi-institutional setting with 90% LRPF rate reproducing exc
43 nd could be delivered to patients in a multi-institutional setting with high compliance rates.